Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Ranibizumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 994Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Bioeq Ag

    02 3Midas Pharma Gmbh

    03 5Novartis Europharm Limited

    04 2Novartis Pharma Schweiz Ag

    05 2Qilu Pharma Spain Sl

    06 1Samsung Bioepis Ch Gmbh

    07 1Samsung Bioepis Nl B.V.

    08 1Samsung Bioepis Nl Bv

    09 1Spirig Healthcare Ag

    10 1Stada Arzneimittel Ag

    11 2Stada Pharmaceuticals Ag

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Midas Pharma Gmbh

    Germany
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Midas Pharma Gmbh

    Germany
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Epruvy

    Dosage Form : Injectable Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 19/09/2024

    Application Number : 20240507000019

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Midas Pharma Gmbh

    Germany
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Midas Pharma Gmbh

    Germany
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Ranivision

    Dosage Form : Injectable Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 25/08/2022

    Application Number : 20210626000016

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Novartis Europharm Limited

    Switzerland
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Novartis Europharm Limited

    Switzerland
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Lucentis

    Dosage Form : Injectable Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 22/01/2007

    Application Number : 20060216000021

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Novartis Europharm Limited

    Switzerland
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Novartis Europharm Limited

    Switzerland
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Lucentis

    Dosage Form : Solution For Injection

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 24/10/2013

    Application Number : 20130518000019

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Novartis Pharma Schweiz Ag

    Switzerland
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Novartis Pharma Schweiz Ag

    Switzerland
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Ranibizumab

    Brand Name : Lucentis

    Dosage Form : Solution For Injection

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 25/08/2006

    Application Number : 57664

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Novartis Pharma Schweiz Ag

    Switzerland
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Novartis Pharma Schweiz Ag

    Switzerland
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Allowed

    Registration Country : Switzerland

    Ranibizumab

    Brand Name : Lucentis

    Dosage Form : Solution For Injection

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 29/01/2014

    Application Number : 63277

    Regulatory Info : Allowed

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Qilu Pharma Spain Sl

    China
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Qilu Pharma Spain Sl

    China
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Rimmyrah

    Dosage Form : Injectable Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 05/01/2024

    Application Number : 20221010000130

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Samsung Bioepis Nl B.V.

    South Korea
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Samsung Bioepis Nl B.V.

    South Korea
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag South Korea
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Byooviz

    Dosage Form : Injectable Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 18/08/2021

    Application Number : 20200911000036

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Stada Pharmaceuticals Ag

    Germany
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Stada Pharmaceuticals Ag

    Germany
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Ximluci

    Dosage Form : Injectable Solution

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 09/11/2022

    Application Number : 20210910000012

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Stada Pharmaceuticals Ag

    Germany
    Aus. Peptide Conference
    Not Confirmed
    arrow

    Stada Pharmaceuticals Ag

    Germany
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Approved

    Registration Country : Sweden

    Ranibizumab

    Brand Name : Ximluci

    Dosage Form : Solution For Injection

    Dosage Strength : 10mg/ml

    Packaging :

    Approval Date : 09/11/2022

    Application Number : 20210910000029

    Regulatory Info : Approved

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF